At MAC Clinical Research, we are committed to ensuring that people living with and beyond cancer have access to groundbreaking clinical trials which aim to deliver improvements in their diagnosis, treatment, clinical outcomes and quality of life.
We are dedicated to ensuring that the latest oncology research innovations are delivered rapidly to the highest standard, on time and to target, across a developing network of investigator sites.
Our oncology CRO capabilities encompass all stages of clinical development, across a variety of anti-cancer therapy induced toxicities, solid tumours, and haematological malignancies. We offer flexible full-service solutions including quality assurance; project management; IMP manufacture and distribution; site feasibility and clinical operations; participant recruitment, engagement, and retention; regulatory affairs and pharmacovigilance; biometrics including data management, SAS programming, medical writing and statistical analysis; and vendor management.
As a CRO partner, MAC can navigate the complexities that oncology clinical trials typically face. Whether that be in protocol development, the intensive logistical management of biomarker-driven precision oncology or operational challenges arising from capacity issues within investigator sites; our clinical research professionals are on hand to help.
We can leverage our scientific and operational expertise to provide the following to meet your oncology research needs: